Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,655 across all filing types
Latest filing 2022-07-11 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
关于控股股东一致行动人部分股份解除质押及再质押的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the release and re-pledging of shares by a controlling shareholder and its concerted parties. It details the number of shares involved, pledge dates, pledgees, and the impact on the company's shareholding structure. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledge status and related shareholder information. It does not fit into financial reports, earnings releases, or management reports. It is a typical regulatory filing about share pledge changes, which is best classified under Regulatory Filings (RNS). The document length is 2872 characters, which is relatively short and consistent with an announcement rather than a full report.
2022-07-11 Chinese
关于认购厦门源峰股权投资基金合伙企业（有限合伙）基金份额的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company's subscription to a private equity investment fund, including extensive information about the fund, its partners, and related entities. It does not contain financial statements, audit opinions, or management discussions of financial results. It is not a transcript, nor a report of voting results or board changes. The document is a regulatory announcement about an investment transaction by the company, describing the investment structure and related parties. It fits best under Capital/Financing Update (CAP) as it relates to the company's capital deployment and investment activities.
2022-07-01 Chinese
2021年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an "Annual Equity Distribution Implementation Announcement" for the year 2021 by Shenzhen BGI Genomics Co., Ltd. It details the dividend distribution plan approved at the 2021 Annual General Meeting held on May 18, 2022, including the dividend amount per share, record date, ex-dividend date, and the method of distribution. The document also references the shareholder meeting resolutions and related consultation contacts. The content is focused on the announcement of the dividend payment details and implementation rather than the full annual report or financial statements. The document length is 3194 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of "Notice of Dividend Amount" (DIV).
2022-06-27 Chinese
国浩律师（深圳）事务所关于深圳华大基因股份有限公司二〇二二年第二次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening and procedures of Shenzhen BGI Genomics Co., Ltd.'s 2022 second extraordinary general meeting of shareholders. It details the legality of the meeting's notice, attendance, voting procedures, and results, confirming compliance with relevant laws and company rules. It does not contain financial statements, earnings data, or management discussion, nor is it a report publication announcement. The document is focused on the legal validation of the shareholder meeting and its voting results, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4984 characters, which is substantial and contains detailed voting results and legal opinions on the meeting's conduct, not just an announcement or notice. Therefore, the best classification is DVA with high confidence.
2022-06-24 Chinese
2022年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the "2022 Second Extraordinary General Meeting of Shareholders" of Shenzhen BGI Genomics Co., Ltd. It details the meeting date, voting procedures, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and voting process. There is no financial data or report content, but rather the official announcement of the voting results from the shareholders' meeting. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)". The document length is about 2596 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is DVA with high confidence.
2022-06-24 Chinese
关于召开2022年第二次临时股东大会的提示性公告
AGM Information Classification · 100% confidence The document is a detailed announcement regarding the convening of the 2022 second extraordinary general meeting (临时股东大会) of Shenzhen BGI Genomics Co., Ltd. It includes information about the meeting date, voting procedures (including online voting), registration details, meeting agenda, and related attachments such as proxy forms and shareholder registration forms. There is no financial data or results presented, nor is it a transcript or presentation. The document serves as a notice or reminder to shareholders about the upcoming meeting and how to participate, which fits the definition of an AGM Information filing (AGM-R). The document length is over 5,000 characters and contains substantive meeting details, not just a brief announcement or link to a report, so it is not a Report Publication Announcement (RPA).
2022-06-21 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.